Objective-Growth factors may play a permissive role in atherosclerosis initiation and progression, in part via their promotion of vascular smooth muscle cell (VSMC) accumulation in plaques. However, unstable human plaques often have a relative paucity of VSMC, which has been suggested to contribute to plaque rupture and erosion and to clinical events. Insulin-like growth factor-1 (IGF-1) is an endocrine and autocrine/paracrine growth factor that is a mitogen for VSMC, but when infused into Apoe Ϫ/Ϫ mice it paradoxically reduces atherosclerosis burden. Methods and Results-To determine the effect of stimulation of VSMC growth on atherosclerotic plaque development and to understand mechanisms of IGF-1's atheroprotective effect, we assessed atherosclerotic plaques in mice overexpressing IGF-1 in smooth muscle cells (SMC) under the control of the ␣-smooth muscle actin promoter, after backcrossing to the Apoe Ϫ/Ϫ background (SMP8/Apoe Ϫ/Ϫ ). Compared with Apoe Ϫ/Ϫ mice, these SMP8/Apoe Ϫ/Ϫ mice developed a comparable plaque burden after 12 weeks on a Western diet, suggesting that the ability of increased circulating IGF-1 to reduce plaque burden was mediated in large part via non-SMC target cells. However, advanced plaques in SMP8/Apoe Ϫ/Ϫ mice displayed several features of plaque stability, including increased fibrous cap area, ␣-smooth muscle actin-positive SMC and collagen content, and reduced necrotic cores. Conclusion-These findings indicate that stimulation of VSMC IGF-1 signaling does not alter total atherosclerotic plaque burden and may improve atherosclerotic plaque stability.
A therosclerosis is the leading cause of mortality in the Western world 1 and is characterized by progression of vascular lesions from early fatty streaks to more advanced plaques characterized by arterial intimal thickening, inflammatory cell and vascular smooth muscle cell (VSMC) accumulation, and extracellular lipid (atheroma) and fibrous tissue deposition. 2, 3 Although migration, proliferation and matrix deposition of VSMC contributes to lesion development, 4 it is unclear whether VSMC accumulation is linked to clinical events. In fact, acute coronary events result more often from erosion or rupture of unstable plaques that have large lipid pools, are rich in lipid-laden macrophages, and have thin fibrous caps, reflecting a relative reduction in VSMC number. 4, 5 Thus, increased intimal accumulation of VSMC could contribute to atherosclerotic plaque stabilization.
Traditionally, the role of growth factors in atherosclerosis has been thought to be permissive and to promote neointima formation. 6 -8 Insulin-like growth factor-1 (IGF-1) is an endocrine and autocrine/paracrine growth factor that exerts pleiotropic effects on cells involved in atherogenesis. 9 Notably, it has mitogenic and antiapoptotic actions on endothelial cells and VSMC and stimulates VSMC migration. 10 Consistent with the role of IGF-1 as a VSMC mitogen, most [11] [12] [13] [14] but not all 15 studies using inhibitors have demonstrated that reduced VSMC IGF-1 signaling correlates with decreased neointimal responses to mechanical arterial injury. Furthermore, targeted overexpression of IGF-1 in SMC increases neointimal formation. 16 However, although mechanical arterial injury models provide much information about the restenotic process, they have significant limitations when addressing mechanisms of atherogenesis, and the role of VSMC IGF-1 in the latter process remains unclear.
We have previously shown that oxidized low-density lipoprotein downregulates IGF-1 and IGF-1 receptor expression in VSMC 17, 18 and that expression of IGF-1 and IGF-1 receptor is reduced in areas of advanced human plaque staining positive for oxidized low-density lipoprotein. 19 These findings suggest that decreased IGF-1 activity could contribute to the atherosclerotic process and notably to depletion of VSMC in advanced unstable plaque. Similar findings have been reported in cultured plaque-derived VSMC. 20 We recently reported that infusion of recombinant human IGF-1 into Apoe-deficient mice on a Western diet for 12 weeks reduced systemic and vascular oxidant stress and vascular proinflammatory cytokine expression and delayed atherosclerosis progression. 21 These unexpected atheroprotective effects of an increase in circulating IGF-1 raised many questions, including that of the target cells involved. We designed the present study to determine the role of VSMC IGF-1 in atherogenesis by crossing SMP8-IGF-1 transgenic mice that overexpress a rat IGF-1 transgene under the control of the ␣-smooth muscle actin (␣SMA) gene promoter 22 into Apoe Ϫ/Ϫ mice. We report that contrary to what could be expected from results of mechanical injury models, overexpression of IGF-1 in VSMC did not alter atherosclerotic plaque burden but increased atherosclerotic plaque VSMC and collagen content and fibrous cap thickness. Our findings suggest that autocrine VSMC IGF-1 signaling promotes atherosclerotic plaque stability.
Methods

Materials
IGF-1 ELISA kits were obtained from Diagnostic Systems Laboratories (Webster, Texas). Dihydroethidium (DHE) was from Invitrogen (Carlsbad, Calif). Oil Red O was from Biomedicals Inc (Irvine, Calif). The antibodies used were anti-␣SMA, anticalponin, and anti-SM22␣ from Abcam; anti-smooth muscle myosin heavy chain from Millipore; and anticollagen type I and III from Rockland Immunochemicals. Polyethylene glycol-superoxide dismutase was from Sigma-Aldrich.
Animals
All animal experiments were performed according to protocols approved by the institutional animal care and use committee. SMP8-IGF-1 transgenic mice (in an FVB background) were obtained from Dr. James A. Fagin (University of Cincinnati, Cincinnati, Ohio). 22 SMP8-IGF-1 transgene-positive mice (SMP8) were identified by polymerase chain reaction (PCR) and bred to Apoe knockout (Apoe Ϫ/Ϫ ) (C57BL/6 background) mice for 8 generations before this line was used for experiments. Twelve SMP8/Apoe Ϫ/Ϫ and 24 Apoe Ϫ/Ϫ mice 8 weeks of age were fed a Western-type diet (42% of total calories from fat, 0.15% cholesterol, Harlan, Indianapolis, Ind) for 12 weeks, and 6 SMP8/Apoe Ϫ/Ϫ and 6 Apoe Ϫ/Ϫ mice 8 weeks of age were fed a Western-type diet for 4 weeks.
Atherosclerosis Quantification
Atherosclerosis burden was quantified by measuring the surface area of Oil Red O-positive lesions on en face preparations of whole aortas as previously described. 21 In addition, serial sections (6 m) were taken throughout the entire aortic valve area as per Paigen et al 23 and stained with H&E for quantitation of plaque cross-sectional area as previously described. 21 The necrotic core was identified as part of the atherosclerotic plaque, which appeared to be acellular (hematoxylin negative) and often contained cholesterol crystals. The area of the SMC fibrous cap was measured using ␣SMA-stained aortic valve sections, with the cap identified as the immunopositive part of the plaque covering the necrotic core. The areas of the necrotic core and fibrous cap were measured using Image-Pro, and data are presented as a percentage of total plaque area.
Immunohistochemical Analysis
Serial 6-m paraffin-embedded cross-sections were taken throughout the entire aortic valve area, and 3 sets of serial sections obtained at 60-m intervals were used for measurement of macrophagepositive lesion area using rat anti-mouse Mac-3 monoclonal antibody as previously described. 21 Serial sections were also stained for tumor necrosis factor-␣ (TNF-␣), ␣SMA, and calponin. Antibodies for immunohistochemistry were purchased from BD Pharmingen (rat anti-mouse Mac-3 antibody), Chemicon/Millipore (mouse ␣SMA antibody), Fitzgerald Industries (rabbit TNF-␣ antibody), and Abcam (rabbit Ki67 and rabbit anti-mouse calponin antibodies). 4Ј,6-Diamidino-2phenylindole was purchased from Invitrogen. Sections were also stained with trichrome (Richard-Allan Scientific, Kalamazoo, Mich) and with picrosirius red (Polysciences Inc, Warrington, Pa). Picrosirius red-stained sections were imaged with a light microscope (Olympus) and also examined under polarized light with a Motic BA300 Pol polarized microscope. 24
Aortic Superoxide Measurement
Aortic superoxide levels were measured with DHE on serial frozen sections (10 m) obtained from the aortic root, as previously described. 21 DHE fluorescence was quantified by averaging the mean fluorescence intensity within 3 identical circles placed on a plaque and adjacent media using Image-Pro and expressed as polyethylene glycol-superoxide dismutase-inhibitable fluorescence after subtraction of the DHE signal obtained from scavengerpretreated section. Three to 5 sections from each animal were analyzed.
Quantitative Real-Time RT-PCR
Total RNA extraction and real-time PCR was performed as previously described. 25 Briefly, total aortic RNA was isolated using the TriPure Isolation Reagent (Roche) followed by purification with the RNeasy mini kit (Qiagen). cDNA was synthesized using the First Strand cDNA Synthesis kit (Amersham) and used for 40-cycle 2-step PCR with sequence-specific primer pairs in the iCycler IQ Real-Time Detection System (Bio-Rad). Primer sequences are provided in the supplemental data, available online at http://atvb.ahajournals.org.
Quantification of Cell Apoptosis and Cell Proliferation
Cell apoptosis was quantified in paraffin-embedded aortic valve cross sections with the Apoptosis TUNEL detection kit (fluorescein) from Roche per the manufacturer's instructions. To identify apoptotic VSMC in the atherosclerotic plaque, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL)-stained sections were costained with ␣SMA antibody (1:1000) followed by incubation with biotinylated secondary antibody and streptavidin-Alexa 594 complex (Invitrogen). Sections were mounted with 4Ј,6-diamidino-2-phenylindole-containing mounting media (Vector Laboratories Inc). Total cell apoptosis was defined as the number of TUNELpositive cells per 1000 plaque cells, and SMC apoptosis was defined as the number of ␣SMA/TUNEL double-positive cells per 1000 ␣SMA-positive cells.
To assess cell proliferation, in vivo labeling of DNA with 5-ethynil-2Ј-deoxyuridine was performed according to Salic et al. 26 5-Ethynil-2Ј-deoxyuridine (5 g/kg per day) was administered i.p. for 4 days before euthanization. The aorta was perfuse fixed and paraffin embedded, and 5-m cross-sections were processed for detection of labeled DNA using Alexa Fluor 488 azide (Clidk-iT Imaging Kit, Invitrogen).
Cell Culture
Cultured human aortic smooth muscle cells (Lonza) were grown in SmBM medium (Lonza) supplemented with 5% fetal calf serum, antibiotics, human recombinant epidermal growth factor, insulin, and human recombinant fibroblast growth factor. The cells were used for experiment at passages 4 to 10. All the experiments were done under serum-free conditions using a 1:1 mixture of Dulbecco's modified essential medium and F-12 nutrient solution (Gibco).
Western Blot Analysis
Western blot analysis was performed as described previously. 27 In brief, cells were washed with PBS and lysed in RIPA buffer, containing 150 mmol/L NaCl, 20 mmol/L Tris-Cl, pH 7.2, 1 mmol/L EDTA, 1% Nonidet P-40, 5 mmol/L dithiothreitol, 0.1 mmol/L phenylmethylsulfonyl fluoride, 1 mmol/L sodium orthovanadate, 0.1 mol/L okadaic acid, 0.1 mol/L aprotinin, 10 g/mL leupeptin, and 10 mmol/L NaF. Lysates were subjected to 10% SDS-PAGE and Western blotting analysis. Immunopositive bands were visualized by enhanced chemiluminescence (Amersham). Blots were stripped and reprobed with monoclonal anti-␤-actin antibody as a control for equal loading.
Statistical Analysis
All numeric data are expressed as meanϮSEM. Two-tailed unpaired Student t tests were performed to determine statistical significance. Differences were considered significant at PϽ0.05.
Results
SMC Targeted Overexpression of IGF-1 in Apoe ؊/؊ Mice Does Not Change Body Weight, Circulating IGF-1 Levels, Blood Pressure, or Total Cholesterol
The mean body weight and systolic blood pressure of SMP8/Apoe Ϫ/Ϫ mice was not different than Apoe Ϫ/Ϫ over the duration of 12 weeks on a Western diet ( Figure 1A and 1B) . Likewise, circulating IGF-1 levels were not different between Apoe Ϫ/Ϫ or SMP8/Apoe Ϫ/Ϫ mice, either at 8 weeks old or after 12 weeks on a Western diet ( Figure 1C ), consistent with the original report from Wang et al, 22 indicating that overexpression of IGF-1 in SMC did not raise circulating IGF-1. 22 However, interestingly, after 12 weeks on this diet both SMP8/Apoe Ϫ/Ϫ and Apoe Ϫ/Ϫ mice had IGF-1 levels that were increased (by 67% and 56%, respectively) compared with baseline IGF-1 levels before initiation of the diet ( Figure 1C ). To confirm that the increase in IGF-1 levels was not agerelated, we performed an additional experiment and measured IGF-1 levels in 20-week-old Apoe Ϫ/Ϫ mice fed normal chow. These levels (193.7Ϯ14.4 ng/mL, nϭ8) were not significantly different from those of 8-week-old Apoe Ϫ/Ϫ mice, indicating that the Western diet raised circulating IGF-1. We used a commercially available assay (EMD Biosciences, San Diego, Calif) to measure total cholesterol levels in serum from SMP8/Apoe Ϫ/Ϫ and Apoe Ϫ/Ϫ mice. SMC-specific IGF-1 overexpression did not change total cholesterol levels (Apoe Ϫ/Ϫ , 1961Ϯ96 mg/dL, nϭ7; SMP8/Apoe Ϫ/Ϫ , 1707Ϯ127 mg/dL, nϭ12; Pϭnot significant).
SMP8/Apoe ؊/؊ Mice Have Increased Vascular IGF-1 Expression and Aortic Hypertrophy
After backcrossing SMP8-IGF-1 mice to the Apoe Ϫ/Ϫ background, we confirmed persistent high-level expression of the IGF-1 transgene in SMP8/Apoe Ϫ/Ϫ mouse aorta by quantitative real-time RT-PCR with oligonucleotide pairs designed specifically for the rat transgene. This transgene was detected only in SMP8/Apoe Ϫ/Ϫ mouse aorta and not in Apoe Ϫ/Ϫ , whereas levels of mouse endogenous IGF-1 transcripts, detected using murine-specific primers, were not different between SMP8/Apoe Ϫ/Ϫ and Apoe Ϫ/Ϫ (data not shown). We also performed quantitative real-time RT-PCR using primers that were conserved between the mouse and rat and found that SMP8/Apoe Ϫ/Ϫ mice had an approximate 15-fold increase in IGF-1 mRNA levels compared with Apoe Ϫ/Ϫ mice ( Figure 1D ).
To determine the effect of SMC-specific IGF-1 overexpression on aortic morphology, we immunostained aortic arch cross-sections from SMP8/Apoe Ϫ/Ϫ and Apoe Ϫ/Ϫ mice for ␣-SMA, a SMC-specific cell marker. SMP8/Apoe Ϫ/Ϫ mice had 35% thicker aortic media (PϽ0.01), 51% larger aortic medial area (PϽ0.01), a 40% increase in lumen area (PϽ0.05), and a 23% increase in outer perimeter (PϽ0.05) compared with Apoe Ϫ/Ϫ mice (Table) . We also assessed medial SMC numbers and found that SMP8/Apoe Ϫ/Ϫ mice had a 35% higher number of medial SMC per section (SMP8/Apoe Ϫ/Ϫ , 762Ϯ49 cells, nϭ5; Apoe Ϫ/Ϫ , 565Ϯ51 cells, nϭ5; PϽ0.05). Thus, IGF-1 appears to proportionally increase the vascular size, consistent with the previous report on SMP8 mice. 22 Figure 1 . SMC-specific overexpression of IGF-1 does not change body weight, systolic blood pressure, or circulating IGF-1 levels. Eight-week-old SMP8/Apoe Ϫ/Ϫ and Apoe Ϫ/Ϫ mice were fed a Western diet for 12 weeks. Body weight (A) and systolic blood pressure (B) were measured weekly, and circulating IGF-1 (C) was measured at weeks 0 and 12. D, Change in aortic IGF-1 mRNA levels in SMP8/Apoe Ϫ/Ϫ mice compared with Apoe Ϫ/Ϫ mice, detected by quantitative real-time RT-PCR using primers common for the rat and mouse IGF-1 gene.
Targeted Overexpression of IGF-1 in SMC Does Not Alter Atherosclerotic Burden, Plaque Macrophage Accumulation, or Oxidative Stress in Apoe ؊/؊ Mice
As shown in Figure 2A , the percentage of total plaque area in mouse aortas after 12 weeks on a Western diet was not different between SMP8/Apoe Ϫ/Ϫ and Apoe Ϫ/Ϫ animals. Likewise, morphometric analysis of aortic valve atherosclerotic plaques revealed that SMP8/Apoe Ϫ/Ϫ and Apoe Ϫ/Ϫ mice had similar lesion sizes ( Figure 2B ). Analysis of aortic valve lesion size at 4 weeks on a Western diet also showed no difference between SMP8/ Apoe Ϫ/Ϫ and Apoe Ϫ/Ϫ mice (Supplemental Figure I ). Because we have previously shown that infusion of IGF-1 in Apoe Ϫ/Ϫ mice reduced plaque macrophage accumulation, plaque TNF-␣ levels, and aortic superoxide levels, 21 we measured the plaque area staining positive for macrophages and found no difference between SMP8/Apoe Ϫ/Ϫ and Apoe Ϫ/Ϫ mice ( Figure 2C ). TNF-␣-immunopositive plaque area was also not different between SMP8/Apoe Ϫ/Ϫ and Apoe Ϫ/Ϫ mice ( Figure 2C, bottom panel) .
To evaluate the potential effect of SMC-specific IGF-1 overexpression on oxidative stress in the atherosclerotic plaque, frozen aortic valve cross-sections from SMP8/Apoe Ϫ/Ϫ and Apoe Ϫ/Ϫ mice were stained with the superoxide-sensitive dye DHE with or without pretreatment with the superoxide-specific scavenger polyethylene glycol-superoxide dismutase. There were higher superoxide levels in the atherosclerotic plaque compared with adjacent media for both mouse strains (SMP8/ Apoe Ϫ/Ϫ , 40% increase; Apoe Ϫ/Ϫ , 77% increase), but neither plaque nor medial superoxide levels were different in SMP8/ Apoe Ϫ/Ϫ mice compared with those of Apoe Ϫ/Ϫ mice, suggesting that increased SMC-specific IGF-1 expression did not alter vascular oxidative stress (data not shown).
Our previous findings indicated that IGF-1 infusion in Apoe Ϫ/Ϫ mice reduced aortic expression of the proinflammatory cytokines interleukin-6 (IL-6) and TNF-␣ and markedly upregulated endothelial nitric oxide synthase expression. 21 As shown in the Table, SMP8/Apoe Ϫ/Ϫ mice had a similar reduction in aortic IL-6 and the same trend in TNF-␣ mRNA levels. However, unlike the effects of an increase in circulating IGF-1, SMC-specific IGF-1 overexpression failed to increase aortic endothelial nitric oxide synthase expression.
SMC-Specific IGF-1 Overexpression Increases Features of Plaque Stability
To determine whether SMC-specific IGF-1 overexpression would alter lesion characteristics and in particular accumulation of VSMC in atherosclerotic plaque, we stained aortic valve cross-sections for VSMC marker proteins, ␣SMA, calponin, and SM22␣. SMP8/Apoe Ϫ/Ϫ mice had a marked increase in ␣SMApositive SMC area in atherosclerotic lesions (111% increase compared with Apoe Ϫ/Ϫ mice, PϽ0.001, Figure 3A ) and a striking 120% increase in fibrous cap area ( Figure 3C ). Areas of plaques staining positive for ␣SMA were also positive for calponin and SM22␣, other markers of differentiated SMC ( Figure 3A) . Calponin-and SM22␣-positive plaque areas were increased by 164% and 93%, respectively, in SMP8/ Apoe Ϫ/Ϫ mice ( Figure 3A ). The number of SMC within plaques (defined as double-positive for 4Ј,6-diamidino-2phenylindole and ␣SMA) was increased in SMP8/Apoe Ϫ/Ϫ mice (SMP8/Apoe Ϫ/Ϫ mice, 99Ϯ8; Apoe Ϫ/Ϫ , 56Ϯ10; nϭ9, PϽ0.01). These data suggest that the increase in smooth muscle marker expression is due to an increase in number of differentiated SMC, although a contribution of SMC hypertrophy cannot be completely excluded. To further evaluate potential direct effects of IGF-1 on smooth muscle differentiation, cultured SMC were exposed to 0 to 100 ng/mL IGF-1 and tested for smooth muscle marker expression. Intriguingly, IGF-1 enhanced smooth muscle myosin heavy chain, ␣SMA, calponin, and SM22␣ expression in a dose-dependent manner (Figure 4) , indicating that IGF-1 promotes SMC differentiation. The increase in fibrous cap area was accompanied by a significant 36% reduction in necrotic core area/total plaque area ( Figure 3C ) and by a marked 305% and 227% increase in plaque collagen content, as determined by trichrome staining and picrosirius red staining (imaged with polarized light), respectively ( Figure 3B ). Imaging of picrosirius red-stained sections using bright field microscopy showed a 406% increase (nϭ6, PϽ0.0001, data not shown). Evaluation of plaque SMC and collagen content at 4 weeks showed a similar increase in smooth muscle-positive area (anti-␣SMA staining, Supplemental Figure IB ) and a strong trend to an increase in plaque collagen (Supplemental Figure IF) . Consistent with these in vivo observations, IGF-1 dosedependently enhanced collagen type I and III expression in cultured aortic SMC ( Figure 4B and 4C) .
Because IGF-1 has strong antiapoptotic effects in cultured aortic SMC, 28 we measured SMC and total cell apoptosis in atherosclerotic plaques of SMP8/Apoe Ϫ/Ϫ and Apoe Ϫ/Ϫ mice. Total and SMC apoptotic rates were not different between the groups at either the 12-week ( Figure 5A atherosclerotic aortas from SMP8/Apoe Ϫ/Ϫ and Apoe Ϫ/Ϫ mice and evaluated Ki67 levels in aortic valve plaques using immunohistochemistry with anti-Ki67 antibody. SMCspecific IGF-1 overexpression did not significantly change Ki67 expression in aortas (Table) or Ki67 positivity in atherosclerotic plaque (Ki67 expression in atherosclerotic plaque at 12 weeks was barely detectable; data not shown). We also evaluated proliferating SMC in plaques at 4 weeks using in vivo labeling with 5-ethynil-2Ј-deoxyuridine and did not find a significant difference (Supplemental Figure IF) .
Discussion
The role of growth factors in atherosclerosis is pleiotropic. A permissive role is illustrated by their ability to stimulate SMC accumulation in developing lesions. [2] [3] [4] 29 This role is supported by results from mechanical injury models in which inhibition of growth factors such as platelet-derived growth factor 30 -32 and IGF-1 11, 12 has resulted in blunted vascular neointimal responses and is the basis for strategies that have successfully been developed to treat restenosis after coronary interventions. 33, 34 However, the role of growth factor-stimulated plaque SMC accumulation in clinical events that are not related to restenosis remains unclear. In fact, clinical studies have indicated that plaques with a relative depletion of VSMC, thin fibrous caps, and increased inflammatory cells are more prone to rupture. 35, 36 We have recently shown that infusion of IGF-1 reduced vascular oxidative stress, inflammation, and atherosclerotic lesion size in Apoe Ϫ/Ϫ mice. 21 IGF-1, via its type 1 receptor, may act on many cell types involved in atherogenesis, including monocyte/macrophages, endothelial cells, and VSMC. Its pleiotropic effects include stimulation of cell proliferation, differentiation, survival, and metabolism. 9 Our current finding that overexpression of IGF-1 in SMC in Apoe Ϫ/Ϫ mice on a Western diet did not result in an increase in plaque burden is contrary to what could be expected based on the increase in IGF-1 expression seen after arterial balloon injury 6, 37 and the robust increase in neointima that occurs in the SMP8-IGF-1 transgenic mouse following mechanical injury. 16 Furthermore, although IGF-1 overexpression did not alter overall plaque burden, it modified plaque composition by markedly increasing VSMC content.
The SMP8-IGF-1 mouse originally described by Wang et al 22 has a marked increase in IGF-1 expression in SMC of the gastrointestinal tract, bladder, uterus, and vasculature, with a 3.5 to 4 fold increase in IGF-1 protein in the aorta and no change in plasma IGF-1 or IGF binding proteins. 22 This allowed us to specifically explore the effect of SMC autocrine/paracrine IGF-1 in atherosclerosis development and progression. After backcrossing this mouse to the Apoe Ϫ/Ϫ background, we confirmed persistent high-level transgene expression. Morphometric analysis showed an increase in aortic outer perimeter, medial area, medial thickness, and lumen size, associated with a higher number of medial SMC (Table) . These findings are consistent with the growth effect of IGF-1 and are similar to those reported by Wang et al. 22 Of note, the increase in SMC mass in the SMP8-IGF-1 mouse was previously shown to be primarily due to SMC hyperplasia, 22 and we confirmed an increase in medial SMC number. We found no change in circulating IGF-1 in SMP8/Apoe Ϫ/Ϫ mice compared with Apoe Ϫ/Ϫ mice. However, interestingly, circulating IGF-1 in Apoe Ϫ/Ϫ mice was increased after 12 weeks on a Western diet. To our knowledge, this finding has not previously been observed. Because circulating IGF-1 is primarily hepatic in origin, this finding suggests that the marked hypercholesterolemia or increase in oxidant stress present in Apoe Ϫ/Ϫ mice induces increased hepatic IGF-1 expression.
The majority of studies exploring mechanical injury models have demonstrated that an increase in IGF-1 or IGF-1 signaling correlates with increased neointimal burden. 14, 16 However, few studies have explored the role of IGF-1 in a hypercholesterolemic mouse model of atherosclerosis. Harrington et al 38 reported that a null mutation for the pregnancy-associated plasma protein-A gene, a metalloproteinase that degrades IGF binding protein 4, reduced lesion size in Apoe Ϫ/Ϫ mice fed a Western diet, potentially via a reduction in IGF-1 bioavailability. How- ever, we have shown that infusion of IGF-1 to Apoe Ϫ/Ϫ mice reduced atherosclerotic plaque macrophage infiltration and lesion burden. 21 This atheroprotective effect was accompanied by a decrease in systemic and vascular oxidant stress, by reduced aortic expression of proinflammatory cytokines, and by an increase in aortic endothelial nitric oxide synthase expression. Our present study indicates that these atheroprotective effects of IGF-1 are likely in large part mediated via non-SMC target cells, because overexpression of IGF-1 in SMC did not recapitulate most of these findings, with the exception of a reduction in aortic TNF-␣ and IL-6 expression.
To our knowledge, this is the first report of a growth factor being overexpressed in SMC in an atherosclerosis model, and our results have significant implications for understanding the role of SMC accumulation in atherogenesis. Our findings suggest that this accumulation can be considered a repair mechanism and suggest that strategies to inhibit VSMC accumulation (outside the specific condition of restenosis) may not be optimal. This may be of particular relevance to advanced atherosclerotic plaques, where a balance between cell death and survival of cells within the fibrous cap, primarily composed of VSMC and extracellular matrix, appears to correlate with plaque instability and stability. 2, 3, 29 Indeed, elegant studies by Clarke et al 39, 40 have shown that chronic apoptosis of VSMC accelerates atherosclerosis in Apoe Ϫ/Ϫ mice. Our findings indicate that IGF-1 overexpression in SMC increases SMC mass and collagen content and reduces necrotic cores in atherosclerotic plaque, resulting in no change in overall plaque burden. Cellular apoptotic rates and indices of cell proliferation (Ki67 expression and 5-ethynil-2Ј-deoxyuridine detection) were not different at 4 and 12 weeks, suggesting that increased proliferation or survival is not the primary determinant of increased plaque SMC content. IGF-1 may induce VSMC migration, 41 and VSMC in atherosclerotic plaque are less differentiated and stain poorly for marker contractile proteins, so it is possible that the marked increase in ␣SMA, calponin, and SM22␣ staining in plaques of SMP8/Apoe Ϫ/Ϫ mice represents IGF-1-induced increases in VSMC migration or differentiation. In fact, our in vitro study using cultured SMC showed that IGF-1 dose-dependently enhanced smooth muscle marker protein expression, namely ␣SMA, calponin, SM22␣, and smooth muscle myosin heavy chain (Figure 4 ). Our data are consistent with prior reports indicating that IGF-1 may regulate the SMC phenotype in vitro [42] [43] [44] and are the first observations suggesting that IGF-1 promotes SMC differentiation in vivo. Our in vitro data also indicate that IGF-1 increased collagen type I and type III expression ( Figure 4B and 4C), and this is consistent with the marked increase in collagen in plaques from SMP8/Apoe Ϫ/Ϫ mice. Collagen production and SMC differentiation have been thought to be inversely related. In this regard, it is noteworthy that areas staining positive for SMC markers and collagen did not coincide in large part (Figure 3 ). In fact, areas positive for SMC marker proteins localized mainly at the surface and shoulder of plaques, whereas core regions of plaques were heavily stained for collagen (trichrome and picrosirius red). Microenvironments for SMC in a plaque differ widely according to their location inside the plaque; for instance, SMC migrated into a core region of the plaque would be extensively exposed to extracellular materials, such as oxidized lipids, which potentially modify SMC phenotype. 45 It is thus possible that SMC in different locations respond differently to IGF-1 as regards expression of marker proteins or synthesis of collagen. Intriguingly, cultured SMC responded to IGF-1 by upregulating both SMC marker expression ( Figure  4A ) and collagen type I and type III expression ( Figure 4B  and 4C ). This effect of IGF-1 appears to be analogous to that of lipid lowering. Indeed, Aikawa et al have shown that lipid lowering in atherosclerotic rabbits produced an increase in SMC differentiation as evidenced by increased expression of smooth muscle myosin heavy chain and an increase in atherosclerotic plaque fibrillar collagen content. 46, 47 These effects were thought to be related to a reduction in both macrophage accumulation and expression of matrix metalloproteinases. It is also important to note that smooth muscle progenitors may be involved in extracellular matrix production, 48, 49 and our study did not assess potential IGF-1 effects on these cells. Our results clearly show that SMP8/Apoe Ϫ/Ϫ mice had no increase in atherosclerotic plaque burden and an unequivocal change in plaque composition, namely an increase in differentiated VSMC with an increase in collagen content and a reduction in necrotic core area. In fact, although there is significant debate about the usefulness of murine model systems for the investigation of acute events such as plaque rupture and thrombosis, these models, including the Apoe Ϫ/Ϫ mouse, are considered relevant tools with which to investigate processes of lesion progression. In particular, phenotypic characteristics of plaque, such as SMC content, fibrous cap thickness, and collagen content, are widely used as indirect indicators of plaque stability. 50, 51 It is of note that Tang et al 52 have shown that deletion of platelet-derived growth factor-B in circulating cells leads to enhanced plaque inflammatory cell infiltration and delays but does not ultimately inhibit SMC accumulation in plaque. Also, cardiac-specific overexpression of transforming growth factor-␤, a growth factor that stimulates VSMC proliferation and matrix protein production, limits atherosclerotic plaque burden in Apoe Ϫ/Ϫ mice. 53 Because aortic lesions in the mouse do not rupture, it will be important to evaluate brachiocephalic arteries in SMP8/ Apoe Ϫ/Ϫ mice, where spontaneous plaque disruption has been reported, 50, 51, 54 to demonstrate potential effects of IGF-1 on plaque stability.
Of course, translation of our findings to clinical studies to explore the use of IGF-1 for plaque stability would require much further work. However, it is important to note that IGF-1 is approved for human use for growth disorders in children and that a complex of IGF-1 and its main circulating binding protein, IGFBP-3, may have advantages versus direct IGF-1 delivery. 55 In summary, this is the first report of targeted overexpression of a growth factor to SMC in atherosclerosis models. Our data indicate that chronic overexpression of IGF-1 in SMC results in no change in atherosclerotic plaque burden in Apoe Ϫ/Ϫ mice fed a high-fat diet and induces a change in lesion composition with features consistent with more stable plaque. Our findings underscore differences in mechanisms between restenosis and atherosclerosis and suggest that stimulation of VSMC IGF-1 signaling may be beneficial for stabilization of atherosclerotic plaques. Our results also indicate that the reduction in atherosclerotic plaque burden produced by an increase in circulating IGF-1 is unlikely to be related to SMC-specific effects of IGF-1.
